RareCyte Closes $22M Financing for Global Commercialization and Platform Expansion into Tissue Multiplexing

SEATTLE, Dec. 19, 2019 /PRNewswire/ — RareCyte, Inc. (“RareCyte” or “the Company”) a Life Sciences company creating liquid and tissue biopsy analysis platforms with emphasis on rare cell detection announced today the completion of a $22M financing from new and existing investors. The…

No Comments

No comments yet.

Sorry, the comment form is closed at this time.